Lisa Peraza
2020
Compensation breakdown
| Non-Equity Incentive Plan | $105,683 |
|---|---|
| Option Awards | $990,829 |
| Salary | $328,805 |
| Stock Awards | $138,855 |
| Other | $14,567 |
| Total | $1,578,739 |
Peraza received $990.8K in option awards, accounting for 63% of the total pay in 2020.
Peraza also received $105.7K in non-equity incentive plan, $328.8K in salary, $138.9K in stock awards and $14.6K in other compensation.
Rankings
In 2020, Lisa Peraza's compensation ranked 6,614th out of 13,090 executives tracked by ExecPay. In other words, Peraza earned more than 49.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,614 out of 13,090 | 50th |
Division Manufacturing | 2,743 out of 5,624 | 51st |
Major group Chemicals And Allied Products | 1,108 out of 2,257 | 51st |
Industry group Drugs | 959 out of 1,957 | 51st |
Industry Pharmaceutical Preparations | 718 out of 1,462 | 51st |
Pay ratio
| Lisa Peraza's Pay | $1,578,739 |
|---|---|
| Median Employee's Pay | $363,920 |
| Pay Ratio | 4to 1 |
In 2020, the annual total compensation of Lisa Peraza was $1,578,739.
The annual total compensation of the median employee at Heron Therapeutics was $363,920.
The ratio of Lisa Peraza's pay to the pay of median employee was therefore 4 to one.
Peraza's colleagues
We found five more compensation records of executives who worked with Lisa Peraza at Heron Therapeutics in 2020.
2020
Barry Quart
Heron Therapeutics
Chief Executive Officer
2020
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
2020
David Szekeres
Heron Therapeutics
Chief Operating Officer
2020
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
2020
Robert Hoffman
Heron Therapeutics